General Information
BioCryst Influenza RELIEF 304
A Phase III, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects with Uncomplicated Influenza. The RELIEF Study (REsearch for aLleviation of Influenza symptoms EFficacy study)
| Protocol | |
|---|---|
| Identifier | BCX1812-304 |
| UID | 9c7eb81a-699f-4d2f-adab-bb8d471d1ba7 |
| Status | Cancelled |
| Phase | 3 |
| Category | Influenza / Mixed Age |
| Launch Year | 0 |
| NCT Number | - |
| Created | 2010-09-16 12:00 |
| Last Updated | 2010-09-16 12:00 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2010-10-26 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | White, Bee | BWhite | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | BioCryst |
|---|---|
| Division | BioCryst |
| Team | BioCryst |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Yellow |
| Currency | - |
